BioCentury
ARTICLE | Company News

Transposagen Biopharmaceuticals, J&J, Poseida Therapeutics deal

June 15, 2015 7:00 AM UTC

Transposagen transferred its gene editing technologies and related IP to its new spinout, Poseida. Transposagen also transferred to Poseida a November 2014 deal with Johnson & Johnson’s Janssen Pharma...